Category Archives: Uncategorized

SphingoTec, BHR Pharmaceuticals ink agreement for distribution of SphingoTec’s acute care portfolio in the UK and Ireland

BHR specializes in innovative diagnostic solutions for point of care Collaboration focuses on SphingoTec’s proprietary assays for bio-ADM®, penKid® and DPP3 Investigator-initiated study in COVID-19 at Guy’s & St Thomas’ Hospital and King's College Hospital NHS Trust Warwickshire, United Kingdom and Hennigsdorf, Germany, September 29, 2020 - BHR Pharmaceuticals Ltd (“BHR”) and SphingoTec GmbH (“SphingoTec”)…
Read more

SphingoTec’s kidney function biomarker penKid® accurately detects acute kidney injury in infants

penKid® (Proenkephalin), a unique biomarker for the real-time assessment of kidney function Novel data now demonstrate that penKid® also accurately predicts acute kidney injury in infants and provides substantial additional value on top of the diagnostic standard of care Hennigsdorf/Berlin, Germany, August 27, 2020 – Diagnostics company SphingoTec GmbH (“SphingoTec”) announced today the publication of…
Read more

SphingoTec Issues Convertible Note Facility

Hennigsdorf, Germany August 19, 2020 – Diagnostic company SphingoTec GmbH (SphingoTec) today announced that the Company has issued a non-brokered, unsecured convertible note facility amounting to EUR 5 million that was fully subscribed by current and new investors. The proceeds of the transaction will bridge to a larger financing round planned for later this year…
Read more

SphingoTec to Present at the Solebury Trout’s Summer Private Company Showcase

Hennigsdorf/Berlin, Germany – August 6, 2020 – Diagnostics company SphingoTec GmbH (“SphingoTec”) today announced that Dr Andreas Bergman, CEO, and Ferdinand Von Humboldt, CFO, will be presenting a corporate overview at the Summer Private Company Showcase, hosted by Solebury Trout on August 10, 2020. SphingoTec develops and markets in-vitro diagnostic tests for novel and proprietary…
Read more

Top